Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colet

Showing results (521-530 of 607) with videos related to

Pageof 61
Sort By:
European Journal of Internal Medicine|March 28, 2024
Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysisSantiago Jiménez-Marrero, Miguel Cainzos-Achirica, David Monterde, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|November 1, 2017
[Consensus on improving the care integrated of patients with acute heart failure]Pere Llorens, Nicolás Manito Lorite, Luis Manzano Espinosa, et al.
European Journal of Heart Failure|March 13, 2022
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiencyJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
Biomolecules|September 27, 2025
Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional StudyMarta Tajes, Maria Del Mar Ras-Jiménez, Josefa Girona, et al.
Scientific Reports|March 14, 2026
Epigenetic alterations in type 1 diabetes and their association with poor glycemic control: the SED1-EPI substudyAna Victoria García, Carmen Lambert, Elsa Villa-Fernández, et al.
Cell Reports|October 14, 2020
Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use DisorderSophie Leclercq, Tiphaine Le Roy, Sonia Furgiuele, et al.
European Journal of Internal Medicine|June 11, 2025
Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factorsPau Llàcer, Marta Cobo Marcos, François Croset, et al.
Journal of Medicinal Chemistry|April 16, 2013
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitorsJalal Soubhye, Iyas Aldib, Betina Elfving, et al.
European Journal of Heart Failure|March 25, 2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiencyStefan D Anker, Piotr Ponikowski, Muhammad Shahzeb Khan, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Pageof 61

Showing results (521-530 of 607) with videos related to

Sort By:
Pageof 61
European Journal of Internal Medicine|March 28, 2024
Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysisSantiago Jiménez-Marrero, Miguel Cainzos-Achirica, David Monterde, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|November 1, 2017
[Consensus on improving the care integrated of patients with acute heart failure]Pere Llorens, Nicolás Manito Lorite, Luis Manzano Espinosa, et al.
European Journal of Heart Failure|March 13, 2022
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiencyJaved Butler, Muhammad Shahzeb Khan, Tim Friede, et al.
Biomolecules|September 27, 2025
Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional StudyMarta Tajes, Maria Del Mar Ras-Jiménez, Josefa Girona, et al.
Scientific Reports|March 14, 2026
Epigenetic alterations in type 1 diabetes and their association with poor glycemic control: the SED1-EPI substudyAna Victoria García, Carmen Lambert, Elsa Villa-Fernández, et al.
Cell Reports|October 14, 2020
Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use DisorderSophie Leclercq, Tiphaine Le Roy, Sonia Furgiuele, et al.
European Journal of Internal Medicine|June 11, 2025
Hypochloremia in chronic and acute heart failure scenarios: Prevalence and risk factorsPau Llàcer, Marta Cobo Marcos, François Croset, et al.
Journal of Medicinal Chemistry|April 16, 2013
Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitorsJalal Soubhye, Iyas Aldib, Betina Elfving, et al.
European Journal of Heart Failure|March 25, 2022
Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiencyStefan D Anker, Piotr Ponikowski, Muhammad Shahzeb Khan, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Pageof 61